ロード中...
Insulin and glucose‐lowering agents for treating people with diabetes and chronic kidney disease
BACKGROUND: Diabetes is the commonest cause of chronic kidney disease (CKD). Both conditions commonly co‐exist. Glucometabolic changes and concurrent dialysis in diabetes and CKD make glucose‐lowering challenging, increasing the risk of hypoglycaemia. Glucose‐lowering agents have been mainly studied...
保存先:
| 出版年: | Cochrane Database Syst Rev |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Ltd
2018
|
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6513625/ https://ncbi.nlm.nih.gov/pubmed/30246878 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011798.pub2 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|